Monday, January 23, 2017

EIGHT-FOLD DRUG TESTING

 

 अष्टांग औषध परीक्षा

 
 
 
 
Dear Young Ayurveda Doctor!
 
For a successful ayurveda treatment, proper use of the drugs is essential.

Unfortunately, not too many tests have been developed to test the efficacy of the proprietary ayurvedic drug formulations available on the market.

The major responsibility of testing the efficacy of the drug formulation, therefore lies on your shoulders, that you would be carrying out while sitting in your clinic.

To enable you do so, here I give an Eight-fold drug testing. Please read every test in detail, and put the same to use in your clinical practice.

Dr.Vasishth


Test - 1
FIRST - LINE DRUGS

You need to ensure that the drugs (ingredients) used in a given proprietary ayurvedic formulation belong to the First Line Drug category of the drugs, described for the management of the diseases, for which the said drug formulation has been indicated. 

For obvious reasons second and third line drugs will not be able to bring about the results equivalent to those of the first line drugs.

For example, for the management of infection the first line drugs are chirayata (sudarshan churna) and ativisha (bal-chatur-bhadra churna). So these should be the primary drugs in the anti-infective proprietary drug formulations. 

Suppose an ayurveda pharma company adds into its anti-infective proprietary drug formulation second or third line anti-infective drugs (manjishtha, sariva etc) as primary drugs, that proprietary drug formulation will not get you the desired results. Using such proprietary drug formulation will get you disrepute and dissatisfaction only.

Conclusion: Avoid proprietary drug formulations that use second and third line drugs as primary drugs.
 
INFEXIE Tablet
Anti-infective, Anti-bacterial


Test - 2
FIRST - LINE DRUGS

You need to ensure that the drugs (ingredients) used in a given proprietary ayurvedic formulation are in therapeutically effective dose.

For obvious reasons, proprietary drug formulations having its ingredient drugs in lower doses will not be able to bring about the desired results.

For example, dose for the churna of a great majority of the medicinal herbs is 3-6 gms. So any proprietary tablet should have its ingredient drugs as follows - 

(i) Ideally each tablet should have 3-6 gm of the churna of the single or multiple herbs. As it will make the tablet too big to be swallowed, it would be adisable that the company makes smaller size tablets (250 mg / 500 mg / 750 mg / 1 g) and advises the dose as follows - 
  • If the tablet size is 250 mg of the churna, one dose shall be of 12-24 tablets;
  • If the tablet size is 500 mg of the churna, one dose shall be of 6-12 tablets;
  • If the tablet size is 750 mg of the churna, one dose shall be of 4-8 tablets; and
  • If the tablet size is 1 g of the churna, one dose shall be of 3-6 tablets.

(ii) Or, the company may use high quality whole extracts of the medicinal herbs, equivalent to the dose of the churna. For examples, a company using 10:1 extract of the medicinal herbs (single or multiple), it should make tablets as follows - 
  • For 3 gms churna, the tablet should contain 300 mg whole extract;
  • For 4 gms churna, the tablet should contain 400 mg whole extract;
  • For 5 gms churna, the tablet should contain 500 mg whole extract; and
  • For 6 gms churna, the tablet should contain 600 mg whole extract.

Suppose an ayurveda pharma company adds into its proprietary drug formulations less than the therapeutically effect dose of a single or multiple drug extracts, such drug formulations will not get you the desired results. Using such proprietary drug formulations will get you disrepute and dissatisfaction only.

Caution: Some companies may play foul by writing on the label : Each tablet contains extracts derived from Guduchi 300 mg (or any other drug).

This is a deceptive practice. Actually these figures mean that it contains 300 mg churna only. The extract is actually only 30 mg.

Conclusion: Avoid proprietary drug formulations that use drugs in less than therapeutically effective dose.
 
PILIE Tablet
Anti-hemorrhoidal


Continued...
 
डाॅ.वसिष्ठ
Dr. Sunil Vasishth
M. + 91-9419205439
Email : drvasishthsunil@gmail.com 

Website : www.drvasishths.com
 

No comments:

Post a Comment